Skip to main content
OpenTrials
Completed

NCT Number: NCT02214641

Resilient, Empowered, Active Living: REAL Diabetes Study

This three-year award will pilot-test an innovative intervention, Resilient, Empowered, Active Living with Diabetes (REAL), targeting underserved minority young adults with poorly-controlled diabetes. The individually tailored, community-based intervention merges findings of an in-depth needs assessment, principles of an evidence-based occupational therapy intervention (Lifestyle Redesign®) and evidence-based diabetes self-management strategies. A proof-of-concept study demonstrated that REAL is feasible to implement, acceptable to young adults with type 1 diabetes and type 2 diabetes, and has potential to produce positive changes in diabetes self-care and glycemic control. The study will randomize 80 young adults with diabetes to receive either the six-month REAL intervention or an attention control condition. Blinded data collectors will assess glycemic control, diabetes self-care behaviors and quality of life outcomes, as well as potential intervention mediators, before and after the six-month intervention. It is anticipated that findings from this pilot study will be used to inform a large-scale randomized controlled trial of the REAL intervention.

The study's specific aims and hypotheses are as follows:

Aim 1. Determine the intervention's efficacy for the primary outcomes: glycemic control and diabetes self-care.

Hypothesis: At 6 months (immediately following the intervention), intervention group participants will demonstrate improvements in A1C and diabetes self-care as compared to control group participants.

Aim 2. Conduct exploratory analyses of the intervention's impact on secondary outcomes and potential mediating mechanisms (to inform power estimates for a large-scale RCT).

Hypothesis 1: At 6 months, intervention group participants will demonstrate improvements in secondary outcomes: diabetes-related stress and quality of life, depression, and life satisfaction as compared to control group participants.

Hypothesis 2: At 6 months, intervention group participants will demonstrate improvements in potential mediators of the intervention: habit strength, problem solving, activity participation, self-efficacy and diabetes knowledge as compared to baseline.

Aim 3. Conduct a process evaluation utilizing mixed methods to evaluate and refine intervention delivery (e.g. treatment fidelity, patient satisfaction) and study procedures (e.g. recruitment, retention, testing protocol).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

USC

Los Angeles, California, 90089, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with type 1 or type 2 diabetes mellitus for a minimum of 12 months
  • Most recent A1C ≥8.0%
  • Fluent in English or Spanish
  • Reachable by telephone or text message
  • Willing to participate in study activities
  • Reside in Los Angeles County with no plans to relocate

Exclusion criteria

  • Pregnant or planning to become pregnant
  • Cognitive impairment or severe disability limiting life expectancy
  • Participated in lifestyle intervention targeting diabetes within past 12 months
  • Participated in formative research related to intervention development.

Treatment and study plan

Resilient, Empowered, Active Living with Diabetes

Behavioral

Individualized lifestyle intervention incorporating the following topics: Diabetes knowledge; access to healthcare; communication with healthcare providers; incorporation of diabetes self-care tasks within daily habits and routines; social support; and emotional well-being. Participants receive a total of 10-16 hours of intervention by a licensed occupational therapist with training in diabetes education, motivational interviewing and the REAL Diabetes intervention protocol.

Information control

Behavioral

Participants will receive a packet of informational materials about diabetes, and receive periodic follow-up phone calls to match for attention dose. The packet of materials will be delivered in an initial home visit. Follow-up phone calls will occur at approximately two week intervals to inquire whether participants have reviewed specific sections of the intervention materials, and clarify information included in the packet.

Primary outcomes

  1. Glycated hemoglobin (HbA1C)

    Time frame: Baseline & 6 months.

    Measure of average blood glucose concentration over approximately the previous 12 weeks.

Secondary outcomes

  1. Audit of Diabetes-Dependent Quality of Life (ADD-QoL)

    Time frame: Baseline & 6 months.

    19-item survey measure assessing impact of diabetes on social, physical, and emotional functioning.

  2. Problem Areas in Diabetes (PAID) Scale - Short Form

    Time frame: Baseline & 6 months.

    5-item survey measure assessing diabetes-related distress and emotional problems.

  3. Patient Health Questionnaire-8 (PHQ-8)

    Time frame: Baseline & 6 months

    8-item survey measure assessing severity of depressive symptoms (identical to PHQ-9 while omitting self-harm item).

  4. Satisfaction With Life Scale (SWLS)

    Time frame: Baseline & 6 months.

    5-item survey measure assessing global life satisfaction and subjective well-being.

  5. Summary of Diabetes Self-Care Activities (SDSCA)

    Time frame: Baseline & 6 months

    14 items assessing diet, physical activity, medication adherence and other self-care behaviors relevant to diabetes.

Sponsors and collaborators

Lead sponsor

University of Southern California

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Official study title

Diabetes Self-Management Lifestyle Intervention for Urban Minority Young Adults

Acronym: REAL

Important dates

Study start
2014
Primary completion
2016
Study completion
2017
First posted
Aug 12, 2014
Registry last updated
Oct 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.